{"disease":{"id":"epidermolysis-bullosa-dystrophica","name":"epidermolysis bullosa dystrophica"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01019148","title":"Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT03269474","title":"Computational Drug Repurposing for All EBS Cases","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Joyce Teng","has_results":false},{"nct_id":"NCT05390073","title":"Growth Hormone in EB","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT05033574","title":"The State of Sexual Development in Children With Inherited Epidermolysis Bullosa","phase":"","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"National Medical Research Center for Children's Health, Russian Federation","has_results":false},{"nct_id":"NCT06177353","title":"Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05843994","title":"Artificial Intelligence Patient App for RDEB SCCs","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT04908215","title":"INM-755 (Cannabinol) Cream for Treatment of Epidermolysis Bullosa","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"InMed Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT03241628","title":"Proof of Concept Study for a Dressing Glove","phase":"","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT01263379","title":"Gene Transfer for Recessive Dystrophic Epidermolysis Bullosa","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Abeona Therapeutics, Inc","has_results":true},{"nct_id":"NCT02810951","title":"A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Castle Creek Biosciences, LLC.","has_results":true},{"nct_id":"NCT04186650","title":"Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Institut National de la Santé Et de la Recherche Médicale, France","has_results":false},{"nct_id":"NCT03605069","title":"A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"Phoenicis Therapeutics","has_results":false},{"nct_id":"NCT03786237","title":"Rigosertib for RDEB-SCC","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Prof. Johann Bauer","has_results":false},{"nct_id":"NCT04171661","title":"Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa","phase":"EARLY_PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1,"lead_sponsor_name":"CHU de Quebec-Universite Laval","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}